Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

PaxVax gets rights to Crucell Switzerland's oral typhoid vaccine

Executive Summary

PaxVax Inc. (infectious disease vaccines) acquired rights to Crucell Switzerland AG’s (formerly Berna Biotech; acquired by Johnson & Johnson in 2010) oral typhoid vaccine Vivotif and its Swiss manufacturing facility.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • Reverse Licensing
    • Marketing-Licensing

Related Companies